Butenafine

HCID 2484

Basic information

CAS
101828-21-1
Standard SMILES
CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12
InChIKey
ABJKWBDEJIDSJZ-UHFFFAOYSA-N
Molecular formula
C23H27N
Average molar mass
317.5 g/mol
Monoisotopic mass
317.21434987

Names & identifiers

Preferred name
Butenafine
IUPAC
1-(4-tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine
English name
Butenafine
Molecular formula
C23H27N
Molecular weight
317.47

Names & synonyms

butenafine101828-21-1ButenafinaButenafinumN-(p-tert-Butylbenzyl)-N-methyl-1-naphthalenemethylamineDTXSID704065791Y494NL0X4-tert-butylbenzyl(methyl)(1-naphthalenemethyl)amineCHEBI:3238DTXCID5020657(4-tert-Butyl-benzyl)-methyl-naphthalen-1-ylmethyl-amine(4-tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine
Show more names
But·NafineButenafine USP/EP/BP4-tert-Butylbenzylmethyl 1-naphtylmethylamine(4-tert-butylbenzyl)-methyl-(1-naphthylmethyl)amineN-methyl-N-(4-methylbenzyl)-N-(1-naphthylmethyl)amineN-(4-tert-Butylbenzyl)-N-methyl-1-naphthalenemethanaminen-methyl-n-(naphthalen-1-ylmethyl)-1-(4-tert-butylphenyl)methanamine
((4-tert-butylphenyl)methyl)(methyl)(naphthalen-1-ylmethyl)amine[(4-tert-butylphenyl)methyl](methyl)(naphthalen-1-ylmethyl)amineRefChem:54581D01AE23Butenafine [INN]Butenafina [INN-Spanish]Butenafinum [INN-Latin]1-(4-tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine

Database identifiers

CAS
101828-21-1
PubChem CID
2484
DTXSID
DTXSID7040657
ChEMBL
CHEMBL990
ChEBI
CHEBI:3238
UNII
91Y494NL0X
Nikkaji
J276.436I

Properties

Computed structural properties

XLogP
6.3
Topological polar surface area
3.2 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
1
Rotatable bonds
5
Heavy atoms
24

Experimental & physicochemical properties

LogP · 2 items

6.6

6.6

Solubility · 2 items

Slightly soluble (HCl salt)

7.56e-05 g/L

Physical DescriptionSolid

Physicochemical properties

Melting point
200 · 200-202 °C
Boiling point
426.1 · 426.1±14.0 °C(Predicted)
Density
1.032 · 1.032±0.06 g/cm3(Predicted)
storage temp.
-20 °C · Store at -20°C
solubility
63 mg/mL · DMSO: 63 mg/mL (198.44 mM);Ethanol: 63 mg/mL (198.44 mM)
pka
7.87 · 7.87±0.50(Predicted)

Safety & regulation

Toxicology

Effects During Pregnancy and Lactation · 1 item

◉ Summary of Use during Lactation;Topical butenafine has not been studied during breastfeeding. Because it is poorly absorbed after topical application, it is not likely to reach the bloodstream of the infant or cause any adverse effects in breastfed infants. Ensure that the infant's skin does not come into direct contact with the areas of skin that have been treated. Only water-miscible cream or gel products should be applied to the breast because ointments may expose the infant to high levels of mineral paraffins via licking.;◉ Effects in Breastfed Infants;Relevant published information was not found as of the revision date.;◉ Effects on Lactation and Breastmilk;Relevant published information was not found as of the revision date.

Chemistry & industry

Pharmacology

ATC Code · 2 items

D - Dermatologicals;D01 - Antifungals for dermatological use;D01A - Antifungals for topical use;D01AE - Other antifungals for topical use;D01AE23 - Butenafine

QD - Dermatologicals;QD01 - Antifungals for dermatological use;QD01A - Antifungals for topical use;QD01AE - Other antifungals for topical use;QD01AE23 - Butenafine

Pharmacodynamics · 1 item

Butenafine is a synthetic antifungal agent that is structurally and pharmacologically related to allylamine antifungals. The exact mechanism of action has not been established, but it is suggested that butenafine's antifungal activity is exerted through the alteration of cellular membranes, which results in increased membrane permeability, and growth inhibition. Butenafine is mainly active against dermatophytes and has superior fungicidal activity against this group of fungi when compared to that of terbinafine, naftifine, tolnaftate, clotrimazole, and bifonazole. It is also active against <i>Candida albicans</i> and this activity is superior to that of terbinafine and naftifine. Butenafine also generates low MICs for <i>Cryptococcus neoformans</i> and <i>Aspergillus spp.</i> as well.

Mechanism of Action · 1 item

Although the mechanism of action has not been fully established, it has been suggested that butenafine, like allylamines, interferes with sterol biosynthesis (especially ergosterol) by inhibiting squalene monooxygenase, an enzyme responsible for converting squalene to 2,3-oxydo squalene. As ergosterol is an essential component of the fungal cell membrane, inhibition of its synthesis results in increased cellular permeability causing leakage of cellular contents. Blockage of squalene monooxygenase also leads to a subsequent accumulation of squalene. When a high concentration of squalene is reached, it is thought to have an effect of directly kill fungal cells.

Biological Half-LifeFollowing topical application, a biphasic decline of plasma butenafine concentrations was observed with the half-lives estimated to be 35 hours initial and over 150 hours terminal.
Metabolism/MetabolitesThe primary metabolite in urine was formed through hydroxylation at the terminal <i>t</i>-butyl side-chain.
FDA Pharmacological Classification · 5 items

91Y494NL0X

BUTENAFINE

Established Pharmacologic Class [EPC] - Benzylamine Antifungal

Chemical Structure [CS] - Benzylamines

Butenafine is a Benzylamine Antifungal.

Applications · 1 item

UsesButenafine (Mentax) is a synthetic benzylamine antifungal agent, related structurally and pharmacologically to terbinafine. It is thought to act by inhibiting the enzyme squalene 2,3-epoxidase, resulting in decreased ergosterol and corresponding increase in squalene, with subsequent cell membrane permeability alteration and cell death. It is active against dermatophytes, yeast, and Sporothrix.

Preparation methods · 1 item

Preparation1. Using 1-naphthoic acid as a raw material, chlorination with thionyl chloride yields 1-naphthoyl chloride, which is then condensed with 1-(4-tert-butylbenzyl)-N-methylmethylamine to give N-(4-tert-butylbenzyl)-N-methyl-1-naphthoamide. This is followed by reduction with lithium aluminum hydride and salt formation to obtain butenafine hydrochloride. 2. Using p-tert-butylbenzoic acid as a raw material, chlorination with thionyl chloride yields p-tert-butylbenzoyl chloride, which is then condensed with N-methylnaphthylmethylamine to give 4-tert-butyl-N-methyl-N-(methylnaphthyl)benzamide. This is followed by reduction with lithium aluminum hydride and salt formation to obtain butenafine hydrochloride. 3. Using naphthalene as a raw material, chloromethylation synthesizes 1-chloromethylnaphthalene, which then reacts with methylamine to generate N-methylnaphthylmethylamine. This is followed by condensation with p-tert-butylbenzyl chloride and salt formation to obtain butenafine hydrochloride. 4. Starting with naphthalene, 1-chloromethylnaphthalene was prepared by chloromethylation, and then substituted with methylamine to obtain the key intermediate N-methyl-1-naphthylmethylamine hydrochloride. This was then condensed with p-tert-butylbenzyl chloride, followed by salt formation and recrystallization to obtain butenafine hydrochloride. 5. N-methyl-1-naphthylmethylamine hydrochloride (2) (41.5 g, 0.20 mol) was added to a mixture of toluene (150 ml) and 10% sodium hydroxide solution (160 g). The mixture was heated to 80 °C, and p-tert-butylbenzyl chloride (3) (40.2 g, 0.22 mol) was added dropwise with stirring over approximately 1 hour. The reaction was continued with stirring for 3 hours. The reaction was stopped, and the organic layer was separated after cooling to room temperature. The organic layer was washed with water until neutral and dried with anhydrous sodium sulfate. After filtration, the toluene was recovered, and the residue was dissolved in an appropriate amount of ethanol. The pH was adjusted to 2 with concentrated hydrochloric acid, and the solvent was recovered to obtain a white crude product (59.8 g). Recrystallization with 50% ethanol yields a white, pure product 1.

Suppliers53 total

北京华美互利生物化工010-56205725 · [email protected]
上海麦克林生化科技股份有限公司021-50706066 15221275939 · [email protected]
广州隽沐生物科技股份有限公司020-36607679; 13502246435 · [email protected]
陕西缔都化学有限公司029-029-81123119 17391733320 · [email protected]
LGM Pharma1-(800)-881-8210 · [email protected]
Additional notes · 1 item

DefinitionChEBI: Trimethylamine in which hydrogen atoms attached to different methyl groups are substituted by 1-naphthyl and 4-tert-butylphenyl groups. It is an inhibitor of squalene epoxidase, an enzyme responsible for the creation of sterols needed in funga cell membranes, and is used as its hydrochloride salt for treatment of dermatological fungal infections.

Related reactions

3 records

Compound notes

Loading…